Key facts
- Notable investors include InCube Ventures, Neuroceuticals.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Theracle
- ·The full record, as it builds
Funding rounds
No funding rounds for Theracle are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Theracle
Developer of medtech platform intended to advance treatment for neurological conditions. The company's platform combines clinical validation, adaptive therapeutic design, and precision monitoring, enabling healthcare providers and research institutions to access neurotechnology that supports better patient outcomes and contributes to improved standards in neurological care.
- Sector
- Healthcare
- HQ
- Milpitas, CA, United States
- Founded
- 2013
- Website
- theracle.com/
- Ownership
- Privately Held (backing)
Theracle doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Theracle shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Theracle in its N-PORT filings yet. We sweep new filings monthly.